newsfilter
← Latest News
Business Wire·

United Therapeutics Corporation to Report Third Quarter 2026 Financial Results Before Market Open on Wednesday, November 4, 2026

  • United Therapeutics will report third quarter 2026 financial results on Wednesday, November 4, 2026, at approximately 6:30 a.m. Eastern Time.
  • A public webcast for the earnings release will be held on Wednesday, November 4, 2026, at 9:00 a.m. Eastern Time accessible at ir.unither.com/events-and-presentations.
  • The webcast rebroadcast will remain available for one year at the same URL.
  • United Therapeutics was founded by CEO Martine Rothblatt to discover a cure for pulmonary arterial hypertension a rare disease affecting her daughter.
  • The company focuses on transforming rare disease treatments pioneering alternatives for transplantable organs operating as a public benefit corporation.
  • The press release includes forward-looking statements regarding organ supply expansion life-saving technologies shareholder value creation sustainable practices.
  • Actual results may differ from forward-looking statements due to risks uncertainties factors detailed in SEC filings including Forms 10-K 10-Q 8-K.
  • The information is provided as of October 21, 2026 with no obligation to update or revise the content.
  • Investor inquiries can be directed to ir.unither.com/contact-ir media inquiries to communications@unither.com.